High-Frequency-Ultrasound Annular Arrays for Ophthalmic Imaging
|ClinicalTrials.gov Identifier: NCT00633854|
Recruitment Status : Unknown
Verified February 2008 by Weill Medical College of Cornell University.
Recruitment status was: Enrolling by invitation
First Posted : March 12, 2008
Last Update Posted : March 12, 2008
|Condition or disease||Intervention/treatment|
|Posterior Vitreous Detachment||Procedure: Ultrasound examination|
In this study, we will deploy annular-array systems and assess their experimental and clinical utility for ophthalmic imaging. We hypothesize that a 20-MHz annular array will detect posterior vitreous detachment (PVD) more reliably than a conventional single element ultrasound system. Clinically, we will test the hypothesis that 20-MHz annular arrays improve detection of PVD, an important risk factor for disease progression in diabetic retinopathy. Diabetic retinopathy is the leading cause of blindness in the working population (25 to 65 years) and the third major cause of legal blindness in the U.S.
We propose to carry out a study of 30 human subjects, aged 60 years or above, in whom PVD is likely to be present as a consequence of normal aging. The study will compare the ability to detect PVD using a commercial ophthalmic ultrasound system equipped with 10- and 20-MHz sector scan probes (Cinescan A/B-S, Quantel Medical), and OCT (OCT/SLO, Ophthalmic Technologies, Inc.), and the 20-MHz annular array. The annular array will be used with synthetic focusing and simulated single-element mode. The end point will be the fraction of eyes in which the PVD is visualized with each technique. This comparison is designed to demonstrate the improvement in our ability to visualize this pathologic entity using the advanced signal processing modes to be explored in this study. PVD can represent a risk factor for retinal detachment and retinal neovascularization in diabetics and localization of vitreoretinal traction points may be crucial for management. The present study, however, is limited to visualization of PVD in older normal subjects, about 75% of which would be expected to have PVD present. Thus, our aim is purely to develop an improved imaging modality rather than demonstrating its clinical efficacy in management of diabetic retinopathy or other ocular diseases.
The imaging technologies that we are developing could potentially result in patents or other intellectual property, which would be managed by the Cornell Research Foundation and Riverside Research Institute. This is alluded to in the consent form for the sake of completeness.
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||High-Frequency-Ultrasound Annular Arrays for Small Animal and Ophthalmic Imaging|
|Study Start Date :||February 2008|
|Estimated Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||January 2012|
30 volunteer subjects who are age 60 and older
Procedure: Ultrasound examination
Immersion Ultrasound Exam: In the immersion technique, the patient lies down on the examination table. A steridrape with a central aperture is used to form a water-tight seal around the eye. After installation of 2 drops of 0.5% proparacaine HCl, a wire lid speculum is used to hold the patient's lids open. Warm 0.9% sterile saline solution is then used to create a waterbath about 1/2 inch deep to provide acoustic coupling between the transducer and the eye. The transducer (either the 10- and 20-MHz sector scan probe or the annular array) is placed in the waterbath, but does not touch the eye.
- detection of PVD in the posterior pole [ Time Frame: outcome measured at time of examination ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00633854
|United States, New York|
|Weill Cornell Medical College|
|New York, New York, United States, 10065|
|Principal Investigator:||Ronald H Silverman, PhD||Weill Medical College of Cornell University|